Liposome bupivacaine — Competitive Intelligence Brief

Liposome bupivacaine (Liposome bupivacaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (liposomal formulation). Area: Anesthesia / Pain Management.

marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels Anesthesia / Pain Management Small molecule

Target snapshot

Liposome bupivacaine (Liposome bupivacaine) — Catherine Vandepitte, M.D.. Liposome bupivacaine is a long-acting local anesthetic that uses liposomal encapsulation to extend the duration of bupivacaine's nerve-blocking effects.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Liposome bupivacaine TARGET	Liposome bupivacaine	Catherine Vandepitte, M.D.	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels
Bupivacaine Spinal 0,5% Heavy - titration	Bupivacaine Spinal 0,5% Heavy - titration	Centre of Postgraduate Medical Education	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels (Nav)
Lacosamide - rapid titration 1	Lacosamide - rapid titration 1	Seoul National University Hospital	marketed	Antiepileptic agent (sodium channel modulator)	Voltage-gated sodium channels (slow inactivation enhancer)
Bupivacaine SNB	Bupivacaine SNB	Pacira Pharmaceuticals, Inc	marketed	Local anesthetic	Voltage-gated sodium channels
Tetracaine drop	Tetracaine drop	University of Miami	marketed	Local anesthetic (ester)	Voltage-gated sodium channels
The ropivacaine group	The ropivacaine group	Beijing Tiantan Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Tetracaine hydrochloride gel	Tetracaine hydrochloride gel	Wenzhou Medical University	marketed	Local anesthetic (ester)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (liposomal formulation) class)

1. Pacira Pharmaceuticals, Inc · 4 drugs in this class
2. Huazhong University of Science and Technology · 1 drug in this class
3. Maimonides Medical Center · 1 drug in this class
4. The Cleveland Clinic · 1 drug in this class
5. The Cooper Health System · 1 drug in this class
6. The University of Texas Health Science Center, Houston · 1 drug in this class
7. Tianjin Medical University General Hospital · 1 drug in this class
8. University of California, Davis · 1 drug in this class
9. Catherine Vandepitte, M.D. · 1 drug in this class
10. Wake Forest University Health Sciences · 1 drug in this class